Grantham, Mayo, Van Otterloo & Co (GMO)’s Core Laboratories CLB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,300	Closed	-$258K	–	507
2014 Q1	$258K	Hold	1,300	–	–	﹤0.01%	539
2013 Q4	$248K	Buy	+1,300	New	+$242K	﹤0.01%	644

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CLB Position: Q2 2014 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 1,300 shares — an estimated $258K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CLB in Q4 2013 and held it in 2 quarters. The position peaked at $258K in Q1 2014. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,300 Core Laboratories shares in Q2 2014, an estimated $258K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Core Laboratories in Q4 2013 and held it in 2 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Core Laboratories position peaked at $258K in Q1 2014.
346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2014, filed 13 Aug 2014.